These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 19193989)
1. Structure of the ligand-binding domain of the EphB2 receptor at 2 A resolution. Goldgur Y; Paavilainen S; Nikolov D; Himanen JP Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):71-4. PubMed ID: 19193989 [TBL] [Abstract][Full Text] [Related]
2. The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism. Xu Y; Robev D; Saha N; Wang B; Dalva MB; Xu K; Himanen JP; Nikolov DB Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638814 [TBL] [Abstract][Full Text] [Related]
3. Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition. Chrencik JE; Brooun A; Recht MI; Nicola G; Davis LK; Abagyan R; Widmer H; Pasquale EB; Kuhn P J Biol Chem; 2007 Dec; 282(50):36505-13. PubMed ID: 17897949 [TBL] [Abstract][Full Text] [Related]
4. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Himanen JP; Chumley MJ; Lackmann M; Li C; Barton WA; Jeffrey PD; Vearing C; Geleick D; Feldheim DA; Boyd AW; Henkemeyer M; Nikolov DB Nat Neurosci; 2004 May; 7(5):501-9. PubMed ID: 15107857 [TBL] [Abstract][Full Text] [Related]
5. Crystal structure of an Eph receptor-ephrin complex. Himanen JP; Rajashankar KR; Lackmann M; Cowan CA; Henkemeyer M; Nikolov DB Nature; 2001 Dec 20-27; 414(6866):933-8. PubMed ID: 11780069 [TBL] [Abstract][Full Text] [Related]
6. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. Koolpe M; Burgess R; Dail M; Pasquale EB J Biol Chem; 2005 Apr; 280(17):17301-11. PubMed ID: 15722342 [TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2. Himanen JP; Henkemeyer M; Nikolov DB Nature; 1998 Dec; 396(6710):486-91. PubMed ID: 9853759 [TBL] [Abstract][Full Text] [Related]
8. The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer. Ebrahim AS; Hailat Z; Bandyopadhyay S; Neill D; Kandouz M Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360867 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the human ephrin-A5 ectodomain. Nikolov D; Li C; Lackmann M; Jeffrey P; Himanen J Protein Sci; 2007 May; 16(5):996-1000. PubMed ID: 17400922 [TBL] [Abstract][Full Text] [Related]
10. The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2. Wagner MJ; Hsiung MS; Gish GD; Bagshaw RD; Doodnauth SA; Soliman MA; Jørgensen C; Tucholska M; Rottapel R J Biol Chem; 2020 Mar; 295(12):3932-3944. PubMed ID: 32060095 [TBL] [Abstract][Full Text] [Related]
11. Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor. Qin H; Shi J; Noberini R; Pasquale EB; Song J J Biol Chem; 2008 Oct; 283(43):29473-84. PubMed ID: 18708347 [TBL] [Abstract][Full Text] [Related]
12. NMR structure and dynamics of human ephrin-B2 ectodomain: the functionally critical C-D and G-H loops are highly dynamic in solution. Ran X; Qin H; Liu J; Fan JS; Shi J; Song J Proteins; 2008 Aug; 72(3):1019-29. PubMed ID: 18300229 [TBL] [Abstract][Full Text] [Related]
13. Unique structure and dynamics of the EphA5 ligand binding domain mediate its binding specificity as revealed by X-ray crystallography, NMR and MD simulations. Huan X; Shi J; Lim L; Mitra S; Zhu W; Qin H; Pasquale EB; Song J PLoS One; 2013; 8(9):e74040. PubMed ID: 24086308 [TBL] [Abstract][Full Text] [Related]
14. Enhanced EphB2-Specific Peptide Inhibitors through Stabilization of Polyproline II Helical Structure. Tennett JC; Epstein SR; Sawyer N ACS Chem Biol; 2024 Jun; 19(6):1214-1221. PubMed ID: 38739742 [TBL] [Abstract][Full Text] [Related]
15. The first identification of complete Eph-ephrin signalling in ctenophores and sponges reveals a role for neofunctionalization in the emergence of signalling domains. Krishnan A; Degnan BM; Degnan SM BMC Evol Biol; 2019 Apr; 19(1):96. PubMed ID: 31023220 [TBL] [Abstract][Full Text] [Related]
16. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth. Chaudhari A; Mahfouz M; Fialho AM; Yamada T; Granja AT; Zhu Y; Hashimoto W; Schlarb-Ridley B; Cho W; Das Gupta TK; Chakrabarty AM Biochemistry; 2007 Feb; 46(7):1799-810. PubMed ID: 17249693 [TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of the binding of monomeric and dimeric ephrins to Eph receptors: correlation to function in a growth cone collapse assay. Pabbisetty KB; Yue X; Li C; Himanen JP; Zhou R; Nikolov DB; Hu L Protein Sci; 2007 Mar; 16(3):355-61. PubMed ID: 17322526 [TBL] [Abstract][Full Text] [Related]